• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于调查研究的克罗恩病指数的开发。

Development of a Crohn's index for survey research.

作者信息

Sandler R S, Jordan M C, Kupper L L

机构信息

Department of Medicine, University of North Carolina, Chapel Hill 27599-7080.

出版信息

J Clin Epidemiol. 1988;41(5):451-8. doi: 10.1016/0895-4356(88)90046-7.

DOI:10.1016/0895-4356(88)90046-7
PMID:3367175
Abstract

Current Crohn's disease activity indices are not suitable for survey research because they rely on information from the laboratory or physical examination. We used data from a multicenter controlled trial of adjuvant sulfasalazine to develop an index of Crohn's disease activity based on information which could be obtained exclusively by interview. The study population consisted of 89 actively symptomatic patients seen on 1082 occasions in eight medical centers. Multiple regression analyses identified three variables which predicted the ratings of physicians: stool frequency, abdominal pain and sense of well-being. The new index correlated very well (r = 0.87, p less than 0.001) with the Crohn's Disease Activity Index from which it was derived. The index may be used in epidemiologic studies to accurately place patients into quartiles of disease severity which correspond to similar quartiles of the CDAI.

摘要

目前的克罗恩病活动指数不适合用于调查研究,因为它们依赖实验室或体格检查的信息。我们利用一项辅助性柳氮磺胺吡啶多中心对照试验的数据,基于仅通过访谈即可获得的信息,制定了一个克罗恩病活动指数。研究人群包括89名有明显症状的患者,他们在8个医疗中心共接受了1082次检查。多元回归分析确定了三个预测医生评分的变量:大便频率、腹痛和幸福感。这个新指数与推导它所依据的克罗恩病活动指数相关性非常好(r = 0.87,p < 0.001)。该指数可用于流行病学研究,以准确地将患者分为疾病严重程度的四分位数,这些四分位数与克罗恩病活动指数(CDAI)的类似四分位数相对应。

相似文献

1
Development of a Crohn's index for survey research.用于调查研究的克罗恩病指数的开发。
J Clin Epidemiol. 1988;41(5):451-8. doi: 10.1016/0895-4356(88)90046-7.
2
Comparison between prospective and retrospective evaluation of Crohn's disease activity index.
Am J Gastroenterol. 2005 May;100(5):1117-20. doi: 10.1111/j.1572-0241.2005.30487.x.
3
A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity.一项回顾性分析:用于评估克罗恩病活动度的患者报告结局指标的发展
Aliment Pharmacol Ther. 2015 Jan;41(1):77-86. doi: 10.1111/apt.13001. Epub 2014 Oct 27.
4
Loperamide oxide for the treatment of chronic diarrhoea in Crohn's disease.氧化洛哌丁胺用于治疗克罗恩病的慢性腹泻。
J Int Med Res. 1995 Sep-Oct;23(5):335-41. doi: 10.1177/030006059502300503.
5
Evaluation of the Crohn's Disease Activity Index (CDAI) and the Dutch Index for severity and activity of Crohn's disease. An analysis of the data from the European Cooperative Crohn's Disease Study.克罗恩病活动指数(CDAI)及荷兰克罗恩病严重程度与活动指数的评估。欧洲克罗恩病合作研究数据的分析。
Med Klin (Munich). 1990 Oct 15;85(10):573-6.
6
Constipating effect of Reasec examined in internal diseases of out-patients.在门诊内科疾病患者中研究了雷贝拉唑的致便秘作用。
Ther Hung. 1979;27(3):134-6.
7
Assessing activity of pediatric Crohn's disease: which index to use?评估儿童克罗恩病的活动度:该使用哪个指标?
Gastroenterology. 1999 Mar;116(3):527-31. doi: 10.1016/s0016-5085(99)70173-3.
8
Rederived values of the eight coefficients of the Crohn's Disease Activity Index (CDAI).克罗恩病活动指数(CDAI)八个系数的重新推导值。
Gastroenterology. 1979 Oct;77(4 Pt 2):843-6.
9
A paediatric Crohn's disease activity index (PCDAI). Is it useful? Study Group on Crohn's Disease in Children and Adolescents.
Acta Paediatr Suppl. 1994 Apr;83(395):22-6. doi: 10.1111/j.1651-2227.1994.tb13224.x.
10
Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings.通过粪便钙卫蛋白和乳铁蛋白评估克罗恩病活动度:与克罗恩病活动指数及内镜检查结果的相关性
Inflamm Bowel Dis. 2008 Jan;14(1):40-6. doi: 10.1002/ibd.20312.

引用本文的文献

1
Estimation of the Harvey Bradshaw Index from the Patient-Reported Outcome 2 in Crohn's Disease: Results Based on a Large Scale Randomized Controlled Trial.基于患者报告结局2评估克罗恩病中的哈维-布拉德肖指数:来自大规模随机对照试验的结果
Inflamm Bowel Dis. 2025 Aug 1;31(8):2097-2105. doi: 10.1093/ibd/izae281.
2
Predicting short-term major postoperative complications in intestinal resection for Crohn's disease: A machine learning-based study.预测克罗恩病肠切除术后短期主要并发症:一项基于机器学习的研究。
World J Gastrointest Surg. 2024 Mar 27;16(3):717-730. doi: 10.4240/wjgs.v16.i3.717.
3
Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.
炎症性肠病症状与影响问卷的编制。
Aliment Pharmacol Ther. 2020 Jun;51(11):1047-1066. doi: 10.1111/apt.15726. Epub 2020 Apr 21.
4
Development and validation of the Crohn's disease patient-reported outcomes signs and symptoms (CD-PRO/SS) diary.克罗恩病患者报告结局体征与症状(CD-PRO/SS)日记的开发与验证
J Patient Rep Outcomes. 2017;2(1):24. doi: 10.1186/s41687-018-0044-7. Epub 2018 May 9.
5
Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale.男性炎症性肠病患者的性功能障碍:一种新的炎症性肠病特异性量表。
Inflamm Bowel Dis. 2018 Jan 18;24(2):310-316. doi: 10.1093/ibd/izx053.
6
A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients.一项关于儿科患者克罗恩病活动、胰高血糖素样肽-2信号传导与肠道功能之间关系的初步研究。
Can J Gastroenterol. 2013 Oct;27(10):587-92. doi: 10.1155/2013/460958.
7
Impact of antibodies to infliximab on clinical outcomes and serum infliximab levels in patients with inflammatory bowel disease (IBD): a meta-analysis.抗英夫利昔单抗抗体对炎症性肠病(IBD)患者临床结局和血清英夫利昔单抗水平的影响:一项荟萃分析。
Am J Gastroenterol. 2013 Jan;108(1):40-7; quiz 48. doi: 10.1038/ajg.2012.363. Epub 2012 Nov 13.
8
Short pediatric Crohn's disease activity index for quality improvement and observational research.用于质量改进和观察性研究的简化小儿克罗恩病活动指数。
Inflamm Bowel Dis. 2011 Jan;17(1):112-7. doi: 10.1002/ibd.21452. Epub 2010 Sep 1.
9
Racial disparities in utilization of specialist care and medications in inflammatory bowel disease.炎症性肠病中专科治疗和药物使用的种族差异。
Am J Gastroenterol. 2010 Oct;105(10):2202-8. doi: 10.1038/ajg.2010.202. Epub 2010 May 18.
10
Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort.门诊队列中克罗恩病患者接受英夫利昔单抗治疗的长期缓解率
Can J Gastroenterol. 2009 May;23(5):348-52. doi: 10.1155/2009/180840.